Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home >Pharma China Archives > Expert Opinions    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Expert Opinions
Inefficient Innovation in China 1/16/2017
How To Think About China's Special Economic Zones As A Foreign Ph... 10/18/2016
Pharma MNCs are on the Defensive. Are They Thinking Clearly? 6/21/2016
Cross-Sector Collaboration to Enhance Market Access for Pharmaceu... 6/8/2016
Pharmaceuticals: China Wishes to Transform Into a Hub for Innovat... 6/2/2016
A Lost Generation of New Products 2/4/2016
A Growing Divide Between Expectations and Reality 11/10/2015
Non-Small Cell Lung Cancer in China: Alarmingly Increased Cancer ... 10/1/2015
Bringing Innovation to China 8/10/2015
Hot Topics Affecting China's OTC and Consumer Healthcare Market 5/20/2015
Are These the Meaningful Changes at the CFDA We've Been Waiting F... 4/21/2015
China's Private Health Insurance: Navigating Uncharted Waters 1/28/2015
China Pharmaceutical Pricing Policy: Painful Reform, High Cost, B... 12/31/2014
China's Evolving Pharma Partnering Landscape: The Right Partner P... 12/12/2014
An Unexpected Reality in the Post-GSK World 11/20/2014
China Healthcare Multi Channel Marketing? OK, But Where? 11/19/2014
China Healthcare Advertising: Failure to Learn 11/19/2014
Lancet: Challenges of Effective Cancer Control in China (External... 8/15/2014
Another Twist in the Ongoing GSK-China Scandal 7/15/2014
The Challenges of Managing China's Highly Fragmented Distributor ... 5/2/2014
IMS: Growing Pains in China 4/28/2014
How China's Anti-Monopoly Laws Could Impact the Pharmaceutical Se... 3/10/2014
Changing R&D and Manufacturing Strategies for MNCs in China 12/23/2013
How MNC's Business Strategy in China Will Change After the GSK Sc... 12/16/2013
How to Succeed in China's Challenging OTC Environment 12/13/2013
Thinking Through the GSK Scandal 9/10/2013
China Offers New Possibilities For Drug License Transfers 7/10/2013
China a Research Superpower But We Could Be Left in Dark 7/7/2013
Innovation & Access in China's Pharmaceutical Market 6/24/2013
"Secondary Bargaining" Cannot Solve High Cost of Medical Treatmen... 5/5/2013
Page:1/3  Total number of articles:90  [1][2][3]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links